dronabinol and hu 308
dronabinol has been researched along with hu 308 in 7 studies
Research
Studies (7)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Buzard, DJ; Han, S; Jones, RM; Thatte, J | 1 |
| Buettner, R; Cravatt, B; Date, R; Di Marzo, V; Gaffal, E; Karsak, M; Mechoulam, R; Petrosino, S; Rehnelt, J; Schlicker, E; Starowicz, K; Steuder, R; Tüting, T; Wang-Eckhardt, L; Werner, S; Zimmer, A | 1 |
| Alroy, I; Aubrey, KR; Harvey, RJ; Lynch, JW; Vandenberg, RJ; Yang, Z | 1 |
| Fernández-Ruiz, J; García, C; García-Arencibia, M; Palomo-Garo, C; Pertwee, R; Ramos, J | 1 |
| Cordomí, A; Guaza, C; Hernangomez, M; López-Rodríguez, ML; Martín-Couce, L; Martín-Fontecha, M; Mestre, L; Ortega-Gutiérrez, S; Palma, S; Palomares, O; Pardo, L | 1 |
| Carreira, EM; Grether, U; Guba, W; Osterwald, A; Sarott, RC; Ullmer, C; Westphal, MV; Zirwes, EA | 1 |
| Bagetta, G; Boccella, S; Corasaniti, MT; Gallo Afflitto, G; Guida, F; Hamamura, K; Maione, S; Nucci, C; Rombolà, L; Sakurada, S; Sakurada, T; Scuteri, D; Tonin, P; Watanabe, C | 1 |
Reviews
2 review(s) available for dronabinol and hu 308
| Article | Year |
|---|---|
Therapeutic utility of cannabinoid receptor type 2 (CB(2)) selective agonists.
Topics: Animals; Drug Design; Humans; Ligands; Models, Molecular; Molecular Conformation; Receptor, Cannabinoid, CB2; Structure-Activity Relationship; Substrate Specificity | 2013 |
Is there a rational basis for cannabinoids research and development in ocular pain therapy? A systematic review of preclinical evidence.
Topics: Animals; Anti-Inflammatory Agents; Cannabidiol; Cannabinoid Receptor Agonists; Cannabinoids; Disease Models, Animal; Dronabinol; Drug Evaluation, Preclinical; Eye Pain; Leukocytes; Lipid Metabolism; Rodentia; Uveitis | 2022 |
Other Studies
5 other study(ies) available for dronabinol and hu 308
| Article | Year |
|---|---|
Attenuation of allergic contact dermatitis through the endocannabinoid system.
Topics: Animals; Arachidonic Acids; Camphanes; Cannabinoid Receptor Modulators; Cannabinoids; Chemokines; Dermatitis, Allergic Contact; Dinitrofluorobenzene; Disease Models, Animal; Down-Regulation; Dronabinol; Endocannabinoids; Female; Glycerides; Mice; Mice, Inbred C57BL; Mice, Knockout; Oligonucleotide Array Sequence Analysis; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Rimonabant; Skin; Up-Regulation | 2007 |
Subunit-specific modulation of glycine receptors by cannabinoids and N-arachidonyl-glycine.
Topics: Arachidonic Acids; Cannabinoids; Cloning, Molecular; DNA, Complementary; Dronabinol; Glycine; Humans; Mutagenesis; Protein Subunits; Receptors, Glycine | 2008 |
Symptom-relieving and neuroprotective effects of the phytocannabinoid Δ⁹-THCV in animal models of Parkinson's disease.
Topics: Animals; Antioxidants; Cannabinoids; Cyclohexanols; Disease Models, Animal; Dopamine; Dronabinol; Glutamic Acid; Lipopolysaccharides; Male; Mice; Motor Activity; Neurons; Neuroprotective Agents; Oxidopamine; Parkinson Disease; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Substantia Nigra; Tyrosine 3-Monooxygenase | 2011 |
Chemical probes for the recognition of cannabinoid receptors in native systems.
Topics: Animals; Biotin; Cannabinoids; Cells, Cultured; Dronabinol; Flow Cytometry; Hippocampus; Humans; Microglia; Molecular Dynamics Simulation; Molecular Probes; Monocytes; Neurons; Neuroprotective Agents; Protein Conformation; Rats; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2 | 2012 |
Highly Selective, Amine-Derived Cannabinoid Receptor 2 Probes.
Topics: Amines; Binding Sites; Cannabinoids; Dronabinol; Humans; Kinetics; Ligands; Molecular Docking Simulation; Protein Binding; Protein Structure, Tertiary; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2 | 2020 |